ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Heart disease"

  • Abstract Number: 0306 • ACR Convergence 2024

    Cardiovascular Risk Estimated with the New PREVENT Calculator and Disease Activity in Patients with Rheumatoid and Psoriatic Arthritis

    Aleydis Gonzalez Melendez1, Rebeca L. Polina-Lugo1, Maria F. Elizondo-Benitez2, Andrea Guajardo Aldaco1, Osvaldo Uresti3, Ricardo I. de la Rosa-Vazquez3, Iris Jazmín Colunga Pedraza1, Dionicio Galarza-Delgado4, jose Ramon Azpiri-Lopez5, Rosa Icela Arvizu-Rivera1 and Jesus Cardenas-de la Garza6, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 4UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 5Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 6Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico

    Background/Purpose: The American Heart Association's PREVENT (Predicting Risk of Cardiovascular Disease EVENTs) is a new calculator developed in 2024, which estimates the 10- and 30-year…
  • Abstract Number: 1958 • ACR Convergence 2024

    Hemodynamic Forces: A Novel Cardiac MRI Parameter to Assess Cardiac Involvement in Sarcoidosis Patients

    Aïcha Kante1, Andreea Afana2, Damien Sène3, Karine Champion3, Valentin Pagis4, William Bigot3, Véronique Delcey5, Amanda Lopes3, Abdellatif Tazi6, Blanca Amador Borrero4, Bruno Crestani7, Claire Baladi8, Valérie Bousson9, Trecy Goncalves10, Edouard Ballout10, Solenn Toupin10, stephane mouly3, Jean-Guillaume Dillinger11, Patrick Henry11, Theo Pezel11 and Cloé Comarmond3, 1Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Université Paris Cité, Paris, Ile-de-France, France, 2Department of Cardiology, University of Medicine and Pharmacy Craiova, Craiova, Romania, 3Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, Ile-de-France, France, 4Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, France, 5Department of Infectious diseases, Lariboisère University Hospital, Paris, Ile-de-France, France, 6National Reference Center for Histiocytoses, Department of Pulmonology, AP-HP, Saint-Louis Hospital, Paris, France, 7National Reference Center for Rare Pulmonary Diseases, Department of Pulmonology, AP-HP, Bichat Hospital, Paris, Ile-de-France, France, 8Université d’Angers, Department of Cardiology, University Hospital of Angers, Angers, France, 9Department of Radiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 10Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, France, 11Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France

    Background/Purpose: Cardiac sarcoidosis (CS) is an underdiagnosed condition characterized by the formation of non-caseating granuloma in the myocardium, potentially leading to arrhythmia, acute heart failure,…
  • Abstract Number: 0347 • ACR Convergence 2024

    Dermato-polymyositis Mortality in U.S. Population: Declining Cancer and Cardiovascular Diseases Among the Leading Underlying Causes of Death over Two Decades

    Elizabeth Matz1 and Ram Singh2, 1UCLA David Geffen School of Medicine, Los Angeles, 2UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: Dermatomyositis and polymyositis (DM/PM) are chronic inflammatory muscle diseases that may cause premature death due to progressive muscle weakness, lung disease, and disease and…
  • Abstract Number: 2009 • ACR Convergence 2024

    Risk of Incident Gout and Cardiovascular Events Within 120 Days of Incident Gout with the Use of Insulin Glargine, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Veterans with Type 2 Diabetes

    Amara Sarwal1, Augustine Takyi1, Guo Wei1, McKenna Nevers1, Ravinder Singh1, Sydney Hartsell1, Robert Boucher1, Niharika Katkam1, Akhil Chakravartula1, Jincheng Shen1, Srinivasan Beddhu1 and Naomi Schlesinger2, 1University of Utah, VA Salt Lake City Health Care System, Salt Lake City, UT, 2University of Utah, Salt Lake City, UT

    Background/Purpose: Previous studies compared the risk of gout with sodium-glucose cotransporter-2 inhibitors (SGLT2i) versus glucagon-like peptide-1 receptor agonists (GLP1-RA), including exendin-4 based GLP1-RA (exenatide and lixisenatide). Synthetic…
  • Abstract Number: 0472 • ACR Convergence 2024

    Impaired Cardiac Function in Contemporary Rheumatoid Arthritis Patients: A Comparative Pilot Study with Cardiovascular Magnetic Resonance-derived Strain Analysis

    Bas Dijkshoorn1, Sreen Mohamed2, Romy Hansildaar2, Henk Everaars3, Geoffrey Mooij3, Luuk Hopman3, Paul Knaapen3, Lourens Robbers3 and Michael Nurmohamed4, 1Amsterdam Rheumatology and immunology Center, Amsterdam, Netherlands, 2Amsterdam Rheumatology and Immunology center location Reade, Amsterdam, Netherlands, 3Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands, Amsterdam, Netherlands, 4Amsterdam University Medical Centers, Amsterdam, Netherlands

    Background/Purpose: Heart failure (HF) is an important, underdiagnosed comorbidity, with increased morbidity and mortality rates in rheumatoid arthritis (RA) patients. The risk of developing HF…
  • Abstract Number: 2026 • ACR Convergence 2024

    Cardiovascular Risk Measured by PREVENT Calculator and Disease Activity in Patients with Systemic Lupus Erythematosus

    Rebeca L. Polina-Lugo1, Aleydis Gonzalez Melendez1, Maria F. Elizondo-Benitez2, Andrea Guajardo Aldaco1, Annette Dominguez-Guerra3, Victoria P. Limas-Martínez1, Iris Jazmín Colunga Pedraza1, Dionicio Galarza-Delgado4, jose Ramon Azpiri-Lopez5, Rosa Icela Arvizu-Rivera1 and Jesus Cardenas-de la Garza6, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 4UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 5Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 6Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico

    Background/Purpose: Increased disease activity by SLEDAI (Systemic Erythematosus Lupus Disease Activity Index) has been associated with higher cardiovascular risk (CVR) and atherosclerotic cardiovascular disease (ASCVD),…
  • Abstract Number: 0556 • ACR Convergence 2024

    Disease Duration, Age and Clinical Features Related to Aortic Valve Sclerosis in Patients with Spondyloarthritis

    Asier García-Alija1, Hye Sang Park1, Patricia Moya1, Ana Laiz1, Carla Marco2, Albert Casals1, Concepcion Pitarch2, Cesar Diaz-Torné1, Berta Paula Magallares3, Ivan Castellvi Barranco1, Susana Fernández-Sánchez1, Andrea García-Guillen2, Jose Luis Tandaipan1, Helena Codes-Mendez1, Guillem Verdaguer1, Luis Sainz1 and Hèctor Corominas1, 1Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2Hospital Dos de Maig, Barcelona, Spain, 3Dept of Rheumatology, Hospital de la Santa Creu I Sant Pau, Barcelona, ES, Barcelona, Spain

    Background/Purpose: Valve degeneration is prevalent in Spondylarthritis (SpA) patients according to descriptive studies, but it is also common in general population. Disease burden may be…
  • Abstract Number: 2046 • ACR Convergence 2024

    Duration of Disease and Long-term Outcomes in Patients with Difficult-to-treat Recurrent Pericarditis: A Chronic Condition Treated with NSAIDs, Colchicine, Corticosteroids, and Anti-IL-1 Agents

    Antonio Brucato1, Elisa Ceriani2, Francesco Agozzino3, Silvia Berra4, Antonio Gidaro2, Silvia Macchi5, Letizia Vena5, Paolo Bindi5, Alberto Pavarani6, Francesco Moda7, Ludovico Luca Sicignano8, Celeste Murace8, Elena Verrecchia8, Caterina Chiara Decarlini9, Silvia Maestroni10, Gabriella Marinaro4, Lucia Trotta3, Massimo Pancrazi3, Lisa Serati3, Enrica Negro3, Claudia Gabiati3, Elisa Calabrò3, Angela Mauro11, Luisa Carrozzo3, Emanuele Bizzi3 and Massimo Imazio12, 1Department of Biomedical and Clinical Sciences, University of Milano, Department of Internal Medicine, Ospedale Fatebeneratelli, Milano, Milano, Lombardia, Italy, 2Department of Internal Medicine, Ospedale Luigi Sacco, Milano, Milan, Italy, 3Department of Internal Medicine, Ospedale Fatebeneratelli, Milano, Milan, Italy, 4Department of Internal Medicine, Ospedale Fatebeneratelli, Milano, Milano, Italy, 5University of Milano, Milan, Italy, 6University of Milano, Milan, 7Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, 8Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Rome, Italy, 9Cardiology Division, Cardiovascular Department, San L. Mandic Hospital, Merate, Lecco, Italy, 10Internal Medicine Department, Papa Giovanni XXIII Hospital, Bergamo, Bergamo, Italy, 11Pediatric Rheumatology Unit, Department of Childhood and Developmental Medicine, Fatebenefratelli-Sacco Hospital, Milan, Italy, 12University of Udine, and Cardiothoracic Department, University Hospital Santa Maria della Misericordia, Udine, Milan, Italy

    Background/Purpose: Recurrent pericarditis (RP) challenges pts and clinicians in terms of long-term management. Objective of this study was to evaluate the remission rate (drug-free for…
  • Abstract Number: 0641 • ACR Convergence 2024

    Predictive Validity of Coronary Artery Calcium Scoring in Low Risk Systemic Lupus Erythematous Patients

    Katherine Chakrabarti1, Apurba Chakrabarti2, Emily Lewis2 and William McCune3, 1University of Michigan, Ann Arbor, MI, 2University of Michigan Hospital, Ann Arbor, MI, 3U Michigan, Ann Arbor, MI

    Background/Purpose: Traditionally, a coronary artery calcium (CAC) score of zero is associated with low rates (0.1-0.2% annualized risk) of major adverse cardiovascular outcomes (MACE). While…
  • Abstract Number: 2227 • ACR Convergence 2024

    Worrisome Mortality Trends over 20 Years Among Patients with Underlying Ischemic Heart Disease and Rheumatoid Arthritis

    Yukthi Mudiam1 and Shreyas Singireddy2, 1Apollo Institute of Medical Sciences and Research, Richmond, TX, 2Department of Cardiology, University of Illinois College of Medicine, Peoria, IL

    Background/Purpose: Ischemic heart disease (IHD) is one of the leading causes of death in the United States. Rheumatoid arthritis (RA), a chronic inflammatory condition affecting…
  • Abstract Number: 0675 • ACR Convergence 2024

    Hydroxychloroquine Induced Cardiomyopathy: A Biopsy Proven Case Series

    Swetapadma Tripathy1, Davina Chen2, Lanny DiFranza3 and Bibi Ayesha4, 1Montefiore Medical Center, Forest Hills, NY, 2Montefiore Medical Center, New Rochelle, NY, 3Montefiore Medical Center, New York City, NY, 4Montefiore Medical Center, Metuchen, NJ

    Background/Purpose: Cardiomyopathy is a rare, life-threatening adverse effect of hydroxychloroquine (HCQ) use. There is a paucity in literature regarding treatment and prognosis in these cases. The aim…
  • Abstract Number: 2429 • ACR Convergence 2024

    Impact of Hydroxychloroquine Level on ECG QTC Interval in Patients with Rheumatic Systemic Autoimmune Diseases: A Real-life Study

    Carmen Raya-Santos1, José Rosas-Gómez de Salazar2, Mariana Marco3, Ana Pons-Bas3, Rocío Gallego Campuzano4, Juan Carlos Cortes4, Lara Pons-Canet3, Maruan Shalabi3, José Miguel Senabre3, José Antonio Bernal5, Gregorio Santos-Soler6, Xavier Barber7 and Jose Alberto Garcia Gomez7, 1Hospital Marina Baixa, Villajoyosa (Alicante), Spain, 2Hospital Marina Baixa, PALMA DE MALLORCA, Comunidad Valenciana, Spain, 3Hospital Marina Baixa, Villajoyosa, Spain, 4Hospital Marina Baixa, Villajoyosa, Comunidad Valenciana, Spain, 5Hospital Marina Baixa (Villajoyosa), Alicante, Spain, 6Hospital Marina Baixa, Villajoyosa, 7Miguel Hernandez University, Villajoyosa, Spain

    Background/Purpose: The administration of hydroxychloroquine-sulphate (HCQ) can lead to the risk of QTc prolongation and cardiac arrhythmias. We evaluated the HCQ concentration and the incidence…
  • Abstract Number: 0683 • ACR Convergence 2024

    Prognostic Value of Systemic Sclerosis-associated Primary Heart Involvement

    Caya Gharibian1, Vanessa Lupi1, Alexander Gotschy1, Mike Becker2, Rucsandra Dobrota1, Muriel Elhai3, Sinziana Muraru1, Suzana Jordan1, Anna-Maria Hoffmann-Vold4, Oliver Distler5, Robert Manka1, Cosimo Bruni1 and Carina Mihai1, 1University Hospital Zurich, University of Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 3University Hospital zurich, Zürich, Switzerland, 4Oslo University Hospital, Oslo, Norway, 5Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Zurich, Switzerland

    Background/Purpose: A definition of primary heart involvement (pHI) in systemic sclerosis (SSc) was recently developed (Bruni C et al. J Scleroderma Relat Disord. 2022;7:24-32). Cardiac…
  • Abstract Number: 0689 • ACR Convergence 2024

    Arrhythmic Burden, Myocardial Markers, and Long-term Survival in Distinct Cardiac Magnetic Resonance Subsets of Systemic Sclerosis

    Silvia Laura Bosello1, Enrico De Lorenzis2, Giacomo De Luca3, Antonio Tonutti4, veronica Batani5, Pier Giacomo Cerasuolo6, Gerlando Natalello7, Lucia Lanzo6, Gabriella Alonzi6, Silvia Fiore6, Stefano Di Murro6, Andrea Zoli6, Valentina Boni6, Riccardo Marano8, Francesca Augusta Gabrielli9, Francesco Del Galdo10, Dan Knight11, Vivek Muthurangu11, Christopher Denton12, Maria De Santis4, Marco Matucci Cerinic5 and Maria Antonietta D'Agostino13, 1Unit of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 2Catholic University of the Sacred Heart, Roma, Rome, Italy, 3Vita-Salute San Raffaele University & IRCCS San Raffaele Hospital, Milan, Milan, Italy, 4Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Italy, 5Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 6Division of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 7Division of Rheumatology - Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Rome, Italy, 8Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Diagnostic Imaging Area, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, 9Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 10University of Leeds, Leeds, United Kingdom, 11UCL Department of Cardiac MRI, University College London (Royal Free Campus), London, United Kingdom, 12University College London, Northwood, United Kingdom, 13Division of Rheumatology, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy

    Background/Purpose: Cardiac involvement in Systemic Sclerosis (SSc) is widely recognized as heterogeneous and, when clinically evident, it is associated with a poor prognosis. Recently, five…
  • Abstract Number: 0705 • ACR Convergence 2024

    Identification of Risk Factors for Incident Cardiomyopathy in Patients with Systemic Sclerosis

    Ji Soo Kim1, Rachel Wallwork1, Carrie Richardson2, Adrianne Woods3, Monica Mukherjee4, Steven Hsu4, Julie Paik1, Christopher Mecoli1, Laura Hummers5, Fredrick Wigley6, Scott Zeger1 and Ami Shah7, 1Johns Hopkins University, Baltimore, MD, 2Northwestern University, Chicago, 3Johns Hopkins University Division of Rheumatology, Baltimore, MD, 4Johns Hopkins University Division of Cardiology, Baltimore, MD, 5Johns Hopkins University, Division of Rheumatology, Baltimore, MD, Ellicott City, MD, 6Johns Hopkins University, Division of Rheumatology, Baltimore, MD, Baltimore, MD, 7Division of Rheumatology, Johns Hopkins University, Ellicott City, MD

    Background/Purpose: Cardiac involvement in systemic sclerosis (SSc) is one of the leading causes of scleroderma-associated death. There are limited data examining risk factors for incident…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology